| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 21,142 | $0.74 | $15,661.99 | +0.1% | +9.3% | +28.5% | |
| Oct 22, 2024 | NPCE Neuropace Inc | Kck Ltd. | 10% Owner | Sell | 4,082 | $6.09 | $24,853.26 | - | +117.7% | +80.7% | |
| Oct 22, 2024 | MLSS Milestone Scientific Inc. | Osser Leonard87 | Director | Sell | 107,984 | $0.93 | $100,425.12 | -2.3% | +56.8% | -46.7% | |
| Oct 22, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 3,100 | $49.68 | $154,001.18 | -6.8% | -38.4% | -83.0% | |
| Oct 22, 2024 | ISRG Intuitive Surgical Inc | Miller Brian Edward | EVP &Chief Digital Officer | Sell | 2,553 | $515.00 | $1,314,795.00 | -26.5% | +16.7% | +1.8% | |
| Oct 21, 2024 | PEN Penumbra Inc | Elsesser Adam62 | CEO And President | Sell | 15,000 | $204.56 | $3,068,366.75 | -0.3% | +29.8% | +20.5% | |
| Oct 21, 2024 | ABT Abbott Laboratories | Allen Hubert L53 | Executive Vice President | Sell | 157,421 | $117.04 | $18,424,298.42 | -15.5% | -0.2% | +9.0% | |
| Oct 21, 2024 | NPCE Neuropace Inc | Kck Ltd. | 10% Owner | Sell | 8,598 | $6.21 | $53,370.50 | - | +110.6% | +74.0% | |
| Oct 21, 2024 | SGHT Sight Sciences, Inc. | Link Matthew66 | Chief Commercial Officer | Sell | 42,318 | $5.79 | $244,900.88 | -3.0% | -47.6% | -6.5% | |
| Oct 18, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 8,104 | $0.75 | $6,061.79 | - | +3.1% | +19.9% | |
| Oct 18, 2024 | SNWV Sanuwave Health, Inc. | Manchester Management Co LLC | Director By Deputization | Buy | 181,818 | $8.25 | $1,499,998.50 | +22.0% | - | - | |
| Oct 18, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 6,205 | $49.94 | $309,850.38 | -3.5% | -38.2% | -83.7% | |
| Oct 17, 2024 | LUNG Pulmonx Corp | French Glendon E. III84 | Director | Sell | 20,000 | $6.52 | $130,400.00 | -1.8% | +4.8% | -76.3% | |
| Oct 17, 2024 | AZTA Azenta, Inc. | Cueto Herman53 | EVP, Chief Financial Officer | Sell | 1,595 | $43.68 | $69,669.60 | -6.1% | +20.2% | -28.8% | |
| Oct 17, 2024 | SGHT Sight Sciences, Inc. | Link Matthew66 | Chief Commercial Officer | Sell | 41,704 | $5.87 | $244,878.10 | -2.8% | -47.7% | -21.2% | |
| Oct 17, 2024 | NPCE Neuropace Inc | Kck Ltd. | 10% Owner | Sell | 46,426 | $6.53 | $303,366.79 | - | +87.8% | +62.9% | |
| Oct 16, 2024 | Davidar David D54 | Director | Sell | 50,000 | $75.04 | $3,751,813.00 | -6.5% | +17.8% | -21.8% | ||
| Oct 16, 2024 | Huller Kelly58 | SVP, GC, Corporate Secretary | Sell | 7,500 | $75.02 | $562,649.25 | -100% | +17.8% | -21.8% | ||
| Oct 16, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 20,000 | $23.23 | $464,500.00 | -3.1% | +14.5% | +20.8% | |
| Oct 15, 2024 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 8,625 | $132.71 | $1,144,648.13 | -3.3% | -51.4% | -14.6% | |
| Oct 15, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 5,000 | $69.51 | $347,533.50 | -9.6% | +3.2% | +5.8% | |
| Oct 15, 2024 | CBLL Ceribell, Inc. | Tpg GP A, LLC77 | 10% Owner | Buy | 380,268 | $17.00 | $6,464,556.00 | +10.6% | -18.4% | -50.5% | |
| Oct 15, 2024 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 25,000 | $72.47 | $1,811,653.29 | -7.7% | +15.0% | -53.2% | |
| Oct 15, 2024 | CBLL Ceribell, Inc. | Tammenoms Bakker Juliet | Director | Buy | 237,234 | $17.00 | $4,032,978.00 | +10.6% | -18.4% | -50.5% | |
| Oct 15, 2024 | PETV Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% Owner | Buy | 718,358 | $0.68 | $485,354.99 | +0.5% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.